Live feed
Filing
SC 13G
SC 13G0000935836-22-000227·GYRE THERAPEUTICS, INC.
Schedule 13G ownership disclosure
CATALYST BIOSCIENCES INC
Security class unavailable · CUSIP: 14888D208
Event date: 2022-02-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,864,115
- Percent of class
- 5.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-22-000227
- Form type
- SC 13G
- Filer
- GYRE THERAPEUTICS, INC.
- CIK
- CIK 1124105
- Filed
- Mar 04, 2022
- Reporting period
- Feb 22, 2022
- Description
- Schedule 13G beneficial ownership